VitaNova Protocol is building an open, AI-native intelligence layer for medicine, biology, and human health. Its goal is to connect biomedical knowledge, clinical context, and artificial intelligence so information can become more useful, explainable, and actionable across research and care. The platform’s proposed infrastructure brings together specialized AI medical agents, a biomedical knowledge layer, and application tools designed for clinical and research settings.

VitaNova describes potential applications including medical imaging and diagnostic workflow support, personalized treatment context, and analysis of complex biological data such as genomics and proteomics. Its agents are intended to help researchers navigate evidence, connect multimodal information, and support clinical reasoning while keeping human expertise central.

The project has announced a strategic cooperation agreement with Stanford Medicine’s Center for Translational Research and Applied Medicine (TRAM), focused on developing AI agents for medicine and biology. VitaNova also states that taxes and fees related to project income will be donated to its established medical charitable fund, supporting healthcare access, research, and public benefit.